Omnicell is trading 13% down at $36.72 after its second-quarter earnings report, as concerns over recurring revenue trends outweighed a beat on the top and bottom lines.
- Management highlighted softer recurring revenue trends and a cautious outlook on new growth conversions, leading to trimmed expectations for the segment.
- Despite raising full-year EPS guidance, the heavy reliance on a one-time $15 million tariff refund for margin expansion appears to be weighing on investor sentiment.